U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
1671116711Isotonic Solution Administration Logistical TestingCompletedNo Results AvailableAcute Kidney InjuryOther: 0.9% sodium chloride|Other: Physiologically balanced fluidhttps://ClinicalTrials.gov/show/NCT02345486
1671216712Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical CystectomyCompletedNo Results AvailableBladder Cancer|Circulating Tumor CellsGenetic: Detection of circulating tumor cells in blood sampleshttps://ClinicalTrials.gov/show/NCT02345473
1671316713Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II StudyRecruitingNo Results AvailablePancreatic Adenocarcinoma|Poorly Differentiated Malignant Neoplasm|Resectable Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer|Undifferentiated PancDrug: Irinotecan Hydrochloride|Drug: Oxaliplatin|Drug: Leucovorin Calcium|Drug: Fluorouracil|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT02345460
1671416714Herbal-Based Medication vs. Placebo in Preventing Acute Otitis Media in Children at High Risk of RecurrenceActive, not recruitingNo Results AvailableAcute Otitis MediaDrug: Herbal-based medication|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02345447
1671516715The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled SubstancesCompletedNo Results AvailableEconomics|Fraud|Delivery of Health Care|Health Expenditures|Centers for Medicare and Medicaid Services (U.S.)Other: Informative letterhttps://ClinicalTrials.gov/show/NCT02345434
1671616716A Study to Identify and Characterize LAL-D Patients in High-risk PopulationsRecruitingNo Results AvailableLysosomal Acid Lipase Deficiencyhttps://ClinicalTrials.gov/show/NCT02345421
1671716717Phase 1b Study of CCX872-B in Patients With Pancreatic AdenocarcinomaRecruitingNo Results AvailablePancreatic CancerDrug: CCX872-Bhttps://ClinicalTrials.gov/show/NCT02345408
1671816718Safety Study of Minimally Invasive Approaches to Unruptured Anterior Circulation AneurysmsRecruitingNo Results AvailableCerebral Aneurysm|Aneurysm, Middle Cerebral Artery|Aneurysm, Anterior Communicating Artery|Aneurysm, Posterior Communicating Artery|Aneurysm, Carotid Artery|Brain AneurysmProcedure: Aneurysm Clippinghttps://ClinicalTrials.gov/show/NCT02345395
1671916719Phase I Dose Escalation of BAY1143572 in Subjects With Acute LeukemiaRecruitingNo Results AvailableLeukemiaDrug: BAY1143572|Drug: BAY1143572https://ClinicalTrials.gov/show/NCT02345382
1672016720Locked Versus Unlocked Set Screws in Intramedullary Fixation of Intertrochanteric FracturesRecruitingNo Results AvailableHip FracturesDevice: Locked Set Screw|Device: Unlocked Set Screwhttps://ClinicalTrials.gov/show/NCT02345369
1672116721Pharmacogenetics of Warfarin in Caribbean HispanicsNot yet recruitingNo Results AvailableAtrial Fibrillation|Deep Vein Thrombosis|Cardiac Valvular Insufficiency|Coagulopathies|Pulmonary EmbolismGenetic: Genotype-guided|Other: Standard-of-Carehttps://ClinicalTrials.gov/show/NCT02345356
1672216722Early Post-Marketing Study of ELIQUIS (Apixaban) in MexicoRecruitingNo Results AvailableDeep Vein Thrombosis|Pulmonary EmbolismDrug: Apixabanhttps://ClinicalTrials.gov/show/NCT02345343
1672316723Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC)RecruitingNo Results AvailableHead and Neck Squamous Cell CarcinomaBiological: Plasmid interleukin-12|Device: Intratumoral electroporationhttps://ClinicalTrials.gov/show/NCT02345330
1672416724Reticular Pseudodrusen Progression StudyRecruitingNo Results AvailableAge-related Macular Degenerationhttps://ClinicalTrials.gov/show/NCT02345317
1672516725Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and DigoxinWithdrawnNo Results AvailableHealthyDrug: Omeprazole|Drug: Warfarin|Drug: BI 1181181|Drug: Midazolam|Drug: Omeprazole|Drug: BI 1181181|Drug: Midazolam|Drug: Midazolam|Drug: Warfarin|Drug: BI 1181181|Drug: Digoxin|Drug: Digoxinhttps://ClinicalTrials.gov/show/NCT02345304
1672616726Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic PatientsRecruitingNo Results AvailableDiabetic Peripheral Neuropathic PainDrug: NRD135S.E1|Drug: Placebo to match NRD135S.E1https://ClinicalTrials.gov/show/NCT02345291
1672716727SUBLIVAC FIX Mite Mixture Dose Tolerability StudyRecruitingNo Results AvailableHouse Dust Mite AllergyDrug: SUBLIVAC FIX Mite mixture|Other: Placebohttps://ClinicalTrials.gov/show/NCT02345278
1672816728Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerNot yet recruitingNo Results AvailableFallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|High Grade Ovarian Serous Adenocarcinoma|Ovarian Endometrioid Tumor|Primary Peritoneal Serous Adenocarcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|RecDrug: Cediranib Maleate|Other: Laboratory Biomarker Analysis|Drug: Olaparib|Other: Pharmacological Studyhttps://ClinicalTrials.gov/show/NCT02345265
1672916729Switch Study to Evaluate the Safety and Efficacy of Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) Fixed Dose Combination (FDC) in HIV-1 Positive Adults Who Are Virologically Suppressed on Emtricitabine/Rilpivirine/Tenofovir Disoproxil FumaActive, not recruitingNo Results AvailableHIV-1 InfectionDrug: FTC/RPV/TAF|Drug: Placebo to match FTC/RPV/TDF|Drug: FTC/RPV/TDF|Drug: Placebo to match FTC/RPV/TAFhttps://ClinicalTrials.gov/show/NCT02345252
1673016730Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 DiabetesNot yet recruitingNo Results AvailableDiabetes MellitusDrug: Pantoprazolehttps://ClinicalTrials.gov/show/NCT02345239
1673116731Study to Evaluate Switching From a Regimen Consisting of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) Fixed Dose Combination (FDC) to Emtricitabine/Rilpivirine/Tenofovir Alafenamide (FTC/RPV/TAF) FDC in Virologically-Suppressed, HIVActive, not recruitingNo Results AvailableHIV-1 InfectionDrug: FTC/RPV/TAF|Drug: Placebo to match EFV/FTC/TDF|Drug: EFV/FTC/TDF|Drug: Placebo to match FTC/RPV/TAFhttps://ClinicalTrials.gov/show/NCT02345226
1673216732A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)RecruitingNo Results AvailableDementia, Lewy Body|Lewy Body DiseaseDrug: E2020|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02345213
1673316733Body Composition and Hormonal Status in Ataxia TelangiectasiaCompletedNo Results AvailableAtaxia TelangiectasiaProcedure: bioelectrical impedance analysis|Procedure: blood drawhttps://ClinicalTrials.gov/show/NCT02345200
1673416734fMRI Study to Investigate Hemodynamic Changes in Brain Resulting From Supplementation of Bacopa Monnieri Extract and Multiple Micronutrient Supplementation.CompletedNo Results AvailableGrowth and DevelopmentDietary Supplement: Beverage powder fortified with Bacopa Monnieri Extract and Multiple Micronutrient supplementation|Dietary Supplement: Non-fortified isocaloric beverage powderhttps://ClinicalTrials.gov/show/NCT02345187
1673516735Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid TumorsRecruitingNo Results AvailableCancerDrug: GSK2849330|Drug: 89Zr-GSK2849330https://ClinicalTrials.gov/show/NCT02345174
1673616736A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)RecruitingNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Triple FF/UMEC/VI|Drug: Placebo to match FF/UMEC/VI|Drug: Budesonide/Formoterol|Drug: Placebo to match Budesonide/Formoterol combination|Drug: Albuterol/salbutamolhttps://ClinicalTrials.gov/show/NCT02345161
1673716737Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult ParticipantsCompletedNo Results AvailableHealthyDrug: Esketaminehttps://ClinicalTrials.gov/show/NCT02345148
1673816738Susceptibility to Infections in Ataxia TelangiectasiaEnrolling by invitationNo Results AvailableAtaxia Telangiectasia|Infections|Immunodeficiency|Lung DiseaseProcedure: Blood collection|Procedure: Lung function measurement|Behavioral: Symptom diaryhttps://ClinicalTrials.gov/show/NCT02345135
1673916739CAMH PARTNERs Integrated Care StudyEnrolling by invitationNo Results AvailableDepression|Anxiety|Alcohol DrinkingBehavioral: Intervention: Mental Health Technician|Other: Enhanced Usual Carehttps://ClinicalTrials.gov/show/NCT02345122
1674016740Clinical Trial of Transtek Body Fat Analyzer (GBF-835-N2 & Other 7 Models)CompletedNo Results AvailableWeight|Body Fat DisorderDevice: Transtek DUT|Device: Referencehttps://ClinicalTrials.gov/show/NCT02345109

* Görseller ve İçerik tekif hakkına sahip olabilir